Laromustine: The return of alkylators to non-myeloablative therapy of AML

Francis J. Giles

doi:10.1016/j.leukres.2009.02.002

Laromustine: The return of alkylators to non-myeloablative therapy of AML

Francis J. Giles^*

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Editorial › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	1022-1023
Number of pages	2
Journal	Leukemia Research
Volume	33
Issue number	8
DOIs	https://doi.org/10.1016/j.leukres.2009.02.002
State	Published - Aug 2009

Keywords

AML
ATG
Alkylating agents
Anthracyclines
Cloretazine
Cytarabine
Elderly
Laromustine
VNP40101M

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.leukres.2009.02.002

Cite this

@article{bef8d5608c5647deb0eb214c6edb10bb,

title = "Laromustine: The return of alkylators to non-myeloablative therapy of AML",

keywords = "AML, ATG, Alkylating agents, Anthracyclines, Cloretazine, Cytarabine, Elderly, Laromustine, VNP40101M",

author = "Giles, {Francis J.}",

year = "2009",

month = aug,

doi = "10.1016/j.leukres.2009.02.002",

language = "English (US)",

volume = "33",

pages = "1022--1023",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd",

number = "8",

}

TY - JOUR

T1 - Laromustine

T2 - The return of alkylators to non-myeloablative therapy of AML

AU - Giles, Francis J.

PY - 2009/8

Y1 - 2009/8

KW - AML

KW - ATG

KW - Alkylating agents

KW - Anthracyclines

KW - Cloretazine

KW - Cytarabine

KW - Elderly

KW - Laromustine

KW - VNP40101M

UR - http://www.scopus.com/inward/record.url?scp=67349127117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349127117&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2009.02.002

DO - 10.1016/j.leukres.2009.02.002

M3 - Editorial

C2 - 19328547

AN - SCOPUS:67349127117

SN - 0145-2126

VL - 33

SP - 1022

EP - 1023

JO - Leukemia Research

JF - Leukemia Research

IS - 8

ER -

Laromustine: The return of alkylators to non-myeloablative therapy of AML

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this